Literature DB >> 23914266

An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction.

Shilo Rosenberg1, Ran Katz, Dov Pode, N Ofer Gofrit, Galina Pizov, Nechushtan Hovav.   

Abstract

We describe an unusual presentation of metastatic lung adenocarcinoma as malignant retroperitoneal fibrosis (MRPF). The diagnostic challenge, due to the small solitary lung mass and absence of a discrete retroperitoneal mass, was overcome by diagnostic laparoscopy. Molecular analysis of tissue acquired was positive for ALK gene rearrangement. Treatment of the patient with crizotinib reversed MRPF. He was weaned off the nephrostomy tubes and is with stable renal function 11 months after diagnosis.

Entities:  

Year:  2013        PMID: 23914266      PMCID: PMC3713148          DOI: 10.5489/cuaj.172

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  12 in total

1.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

Review 2.  Retroperitoneal fibrosis.

Authors:  E S Amis
Journal:  AJR Am J Roentgenol       Date:  1991-08       Impact factor: 3.959

3.  Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.

Authors:  Hye Ryun Kim; Hyo Sup Shim; Jin-Haeng Chung; Young Joo Lee; Yun Kyoung Hong; Sun Young Rha; Se Hoon Kim; Sang-Jun Ha; Se Kyu Kim; Kyung Young Chung; Ross Soo; Joo Hang Kim; Byoung Chul Cho
Journal:  Cancer       Date:  2011-06-30       Impact factor: 6.860

4.  Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.

Authors:  Alice T Shaw; Beow Y Yeap; Mari Mino-Kenudson; Subba R Digumarthy; Daniel B Costa; Rebecca S Heist; Benjamin Solomon; Hannah Stubbs; Sonal Admane; Ultan McDermott; Jeffrey Settleman; Susumu Kobayashi; Eugene J Mark; Scott J Rodig; Lucian R Chirieac; Eunice L Kwak; Thomas J Lynch; A John Iafrate
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

Review 5.  Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Authors:  M Grunnet; J B Sorensen
Journal:  Lung Cancer       Date:  2011-12-06       Impact factor: 5.705

Review 6.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

7.  Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Authors:  Doron Lipson; Marzia Capelletti; Roman Yelensky; Geoff Otto; Alex Parker; Mirna Jarosz; John A Curran; Sohail Balasubramanian; Troy Bloom; Kristina W Brennan; Amy Donahue; Sean R Downing; Garrett M Frampton; Lazaro Garcia; Frank Juhn; Kathy C Mitchell; Emily White; Jared White; Zac Zwirko; Tamar Peretz; Hovav Nechushtan; Lior Soussan-Gutman; Jhingook Kim; Hidefumi Sasaki; Hyeong Ryul Kim; Seung-il Park; Dalia Ercan; Christine E Sheehan; Jeffrey S Ross; Maureen T Cronin; Pasi A Jänne; Philip J Stephens
Journal:  Nat Med       Date:  2012-02-12       Impact factor: 53.440

8.  Metastatic disease of the ureter: patterns of tumoral spread and radiologic findings.

Authors:  B Marincek; J R Scheidegger; U E Studer; R Kraft
Journal:  Abdom Imaging       Date:  1993

Review 9.  ALK in lung cancer: past, present, and future.

Authors:  Alice T Shaw; Jeffrey A Engelman
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

10.  Metastatic ureteral involvement of non-small cell lung cancer.

Authors:  Koichi Kodama; Tetsuya Imao; Kazuto Komatsu
Journal:  Case Rep Med       Date:  2011-03-30
View more
  1 in total

1.  Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.

Authors:  Hiroki Ota; Tomohiro Ota; Eriko Narisawa; Hideyuki Chiba; Hiroshi Nakayama; Yoko Tsukumo; Atsuhiko Sakamoto; Naoko Honma
Journal:  Intern Med       Date:  2020-07-28       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.